<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Belenki D</submitter><funding>Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)</funding><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Deutsche Forschungsgemeinschaft (German Research Foundation)</funding><funding>Bundesministerium für Gesundheit</funding><funding>Deutsche Krebshilfe</funding><funding>Bundesministerium für Gesundheit (Federal Ministry of Health, Germany)</funding><funding>Deutsche Krebshilfe (German Cancer Aid)</funding><pagination>3079</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11955568</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Cellular senescence is a stress-inducible state switch relevant in aging, tumorigenesis and cancer therapy. Beyond a lasting arrest, senescent cells are characterized by profound chromatin remodeling and transcriptional reprogramming. We show here myeloid-skewed aberrant lineage plasticity and its immunological ramifications in therapy-induced senescence (TIS) of primary human and murine B-cell lymphoma. We find myeloid transcription factor (TF) networks, specifically AP-1-, C/EBPβ- and PU.1-governed transcriptional programs, enriched in TIS but not in equally chemotherapy-exposed senescence-incapable cancer cells. Dependent on these master TF, TIS lymphoma cells adopt a lineage-promiscuous state with properties of monocytic-dendritic cell (DC) differentiation. TIS lymphoma cells are prefe</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.</pubmed_title><pmcid>PMC11955568</pmcid><funding_grant_id>e:Med program project SeneSys: 031L0189A</funding_grant_id><funding_grant_id>European Union ERA PerMed, HiRisk-HiGain</funding_grant_id><funding_grant_id>GO 2688/1 1</funding_grant_id><funding_grant_id>SCHM 1633/9-2</funding_grant_id><funding_grant_id>7011377629</funding_grant_id><funding_grant_id>SCHM 1633/11-1</funding_grant_id><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Kandler G</pubmed_authors><pubmed_authors>Scharnagl E</pubmed_authors><pubmed_authors>Reimann M</pubmed_authors><pubmed_authors>Dorr JR</pubmed_authors><pubmed_authors>Brzezicha B</pubmed_authors><pubmed_authors>Shao Z</pubmed_authors><pubmed_authors>Pardon K</pubmed_authors><pubmed_authors>Schonlein M</pubmed_authors><pubmed_authors>Wolf J</pubmed_authors><pubmed_authors>Bischof O</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors><pubmed_authors>Belenki D</pubmed_authors><pubmed_authors>Nabuco Leva Ferreira de Freitas JA</pubmed_authors><pubmed_authors>Hick TP</pubmed_authors><pubmed_authors>Chapuy B</pubmed_authors><pubmed_authors>Schmitt CA</pubmed_authors><pubmed_authors>Milanovic M</pubmed_authors><pubmed_authors>Leser U</pubmed_authors><pubmed_authors>Scheidereit C</pubmed_authors><pubmed_authors>Bhattacharya A</pubmed_authors><pubmed_authors>Fan DNY</pubmed_authors><pubmed_authors>Bittner A</pubmed_authors><pubmed_authors>Kase J</pubmed_authors><pubmed_authors>Du J</pubmed_authors><pubmed_authors>Richter-Pechanska P</pubmed_authors><pubmed_authors>Lau A</pubmed_authors><pubmed_authors>Cai X</pubmed_authors><pubmed_authors>Thiessen N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.</name><description>Cellular senescence is a stress-inducible state switch relevant in aging, tumorigenesis and cancer therapy. Beyond a lasting arrest, senescent cells are characterized by profound chromatin remodeling and transcriptional reprogramming. We show here myeloid-skewed aberrant lineage plasticity and its immunological ramifications in therapy-induced senescence (TIS) of primary human and murine B-cell lymphoma. We find myeloid transcription factor (TF) networks, specifically AP-1-, C/EBPβ- and PU.1-governed transcriptional programs, enriched in TIS but not in equally chemotherapy-exposed senescence-incapable cancer cells. Dependent on these master TF, TIS lymphoma cells adopt a lineage-promiscuous state with properties of monocytic-dendritic cell (DC) differentiation. TIS lymphoma cells are prefe</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-01T07:44:10.44Z</modification><creation>2026-04-08T10:29:46.775Z</creation></dates><accession>S-EPMC11955568</accession><cross_references><pubmed>40159497</pubmed><doi>10.1038/s41467-025-57429-x</doi></cross_references></HashMap>